Lb Pharmaceuticals Common Stock Buy Hold or Sell Recommendation
| LBRX Stock | 21.53 0.47 2.14% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding LB Pharmaceuticals Common is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell LB Pharmaceuticals Common given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for LB Pharmaceuticals Common, the advice is generated through an automated system that utilizes algorithms and statistical models.Check out LB Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as LBRX and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards LB Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Execute LB Pharmaceuticals Buy or Sell Advice
The LBRX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on LB Pharmaceuticals Common. Macroaxis does not own or have any residual interests in LB Pharmaceuticals Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute LB Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Good | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Strong | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
LB Pharmaceuticals Trading Alerts and Improvement Suggestions
| LB Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| LB Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (63.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LB Pharmaceuticals generates negative cash flow from operations | |
| LB Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Medline sets terms for 5.37bn healthcare IPO - BioXconomy |
LB Pharmaceuticals Returns Distribution Density
The distribution of LB Pharmaceuticals' historical returns is an attempt to chart the uncertainty of LB Pharmaceuticals' future price movements. The chart of the probability distribution of LB Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use LB Pharmaceuticals Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of LB Pharmaceuticals returns is essential to provide solid investment advice for LB Pharmaceuticals.
| Mean Return | 0.69 | Value At Risk | -5.55 | Potential Upside | 7.62 | Standard Deviation | 4.43 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of LB Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
LB Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to LB Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that LB Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LBRX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.66 | |
β | Beta against Dow Jones | 0.27 | |
σ | Overall volatility | 4.53 | |
Ir | Information ratio | 0.14 |
LB Pharmaceuticals Volatility Alert
LB Pharmaceuticals Common shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure LB Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact LB Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.LB Pharmaceuticals Fundamentals Vs Peers
Comparing LB Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze LB Pharmaceuticals' direct or indirect competition across all of the common fundamentals between LB Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as LB Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of LB Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing LB Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare LB Pharmaceuticals to competition |
| Fundamentals | LB Pharmaceuticals | Peer Average |
| EBITDA | (63.01 M) | 3.9 B |
| Net Income | (63.1 M) | 570.98 M |
| Total Debt | 3.7 M | 5.32 B |
| Cash Flow From Operations | (53.05 M) | 971.22 M |
| Number Of Employees | 16 | 18.84 K |
| Total Asset | 33.53 M | 29.47 B |
| Retained Earnings | (104.32 M) | 9.33 B |
| Working Capital | 20.77 M | 1.48 B |
| Net Asset | 33.53 M |
LB Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as LBRX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5774.15 | |||
| Daily Balance Of Power | (0.55) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 21.68 | |||
| Day Typical Price | 21.63 | |||
| Price Action Indicator | (0.38) | |||
| Period Momentum Indicator | (0.47) |
About LB Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell LB Pharmaceuticals Common? Buying financial instruments such as LBRX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having LB Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy ETFs Thematic Idea Now
Energy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 96 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for LBRX Stock Analysis
When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.